Drug Profile
Research programme: TRAIL receptor 2 agonist - Affymax
Alternative Names: TRAIL R2 research programme - Affymax; Tumour necrosis factor-related apoptosis-inducing ligand receptor-2 - AffymaxLatest Information Update: 27 Aug 2009
Price :
$50
*
At a glance
- Originator Affymax
- Class Peptides
- Mechanism of Action TRAIL receptor 2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 20 Jun 2005 Preclinical trials in Cancer in USA (unspecified route)